Press release from Companies
Published: 2024-12-10 14:00:00
held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”) on
Tuesday, 10 December 2024 at 09:00 am (CET)
On 10 December 2024 at 9:00 am (CET), an extraordinary general meeting was held in the Company at the Company’s address, Rugvænget 5, 6823 Ansager, Denmark.
The agenda for the extraordinary general meeting was as follows:
|
Proposed resolution to elect one (1) new additional member of the board of directors (proposed by the board of directors) |
|
Proposed resolution to issue shares to members of the executive board and board of directors of the Company without pre-emption rights for the Company’s shareholders and to increase the share capital in this connection, including consequential amendments to the articles of association. (proposed by the board of directors) |
|
Proposed resolution to issue warrants to members of the executive board and the board of directors of the Company without pre-emption rights for the Company’s shareholders and to resolve the potential increase of the share capital in this connection, including consequential amendments to the articles of association. (proposed by the board of directors) |
Lawyer Michael Kristensen was appointed chairman of the meeting pursuant to clause 11.20 of the Company’s articles of association.
The chairman of the meeting announced that the general meeting had been duly convened, as the notice of the extraordinary general meeting was given on 25 November 2024. The chairman of the meeting described the formal requirements with respect to the notice and concluded that these were met.
The chairman concluded that the general meeting formed a quorum with respect to the agenda.
A total of 559,582,639 votes were represented on the general meeting divided between 551,675,663 votes by post (written votes) and 7,906,976 votes by those shareholders in physical attendance.
Re 1
It was proposed:
(i) to elect one (1) additional member of the board of directors; and
(ii) that Jes Lunde shall be elected as the additional member of the board of directors.
The proposal to elect one (1) additional member of the board of directors is set forth in order to adhere to Spotlight Stock Market’s Regulations according to which the board of directors must consist of minimum 4 members.
All existing members of the board of directors shall remain in the board of directors.
Managerial posts held by Jes Lunde were enclosed as a schedule to the notice of the general meeting.
The proposal to elect one (1) additional member of the board of directors was adopted by the general meeting, as the votes were cast as follows:
- 513,849,021 votes: “for” (equal to 91.83% of the share capital represented on the general meeting)
- 40,733,618 votes: “against”
- 5,000,000 votes: “abstain”
Jes Lunde was elected as a new member of the board of directors by uncontested election.
Re 2
It was proposed to increase the share capital of the company by nominally DKK 200,000 from nominally DKK 3,791,101.234 to nominally DKK 3,991,101.234 against cash payment.
The terms of the proposed increase of the share capital are as follows:
- Jeppe Krog Rasmussen, CEO and board member (subscribes for 75,000,000 shares)
- Carsten Trads, Chairman of the board of directors (subscribes for 62,500,000 shares)
- Christian Carlsen, vice-chairman of the board of directors (subscribes for 12,500,000 shares)
- Jes Lunde (proposed as new member of the board of directors under item 1) (subscribes for 50,000,000 shares)
Adoption of the proposal will imply that clause 3.1 of the articles of association will be amended to reflect the new share capital (as set out in new articles of association attached as Schedule 1 to these minutes).
Draft new articles of association were presented.
The proposal was adopted by the general meeting, as the votes were cast as follows:
- 514,275,976 votes: “for” (equal to 91.90% of the share capital represented on the general meeting)
- 45,306,663 votes: “against”
Re 3
It was proposed to issue up to 100,000,000 warrants, each granting the right to subscribe for one (1) share of nominally DKK 0.001, and to resolve the related capital increase.
The full set of terms of the proposed issue of warrants and the related capital increase is set out in new clause 7.1 and Schedule A to the articles of association (see Schedule 1 to this notice).
The most essential terms of the proposed issue and the related capital increase are as follows:
- Jeppe Krog Rasmussen, CEO and board member (subscribes for 37,500,000 warrants)
- Carsten Trads, Chairman of the board of directors (subscribes for 31,250,000 warrants)
- Christian Carlsen, vice-chairman of the board of directors (subscribes for 6,250,000 warrants)
- Jes Lunde (proposed as new member of the board of directors under item 1) (subscribes for 25,000,000 warrants)
Adoption of the proposal will imply that a new clause 7.1 is inserted in the articles of association, and that Schedule A to the articles of association is amended to include warrants issued under clause 7.1 (see Schedule 1 to this notice).
Draft new articles of association, including new Schedule A, were presented.
The proposal was adopted by the general meeting, as the votes were cast as follows:
- 514,275,976 votes: “for” (equal to 91.90% of the share capital represented on the general meeting)
- 45,306,663 votes: “against”
------
The meeting was closed.
Chairman of the meeting:
__________________________
Michael Kristensen